Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
The expression of selected microRNAs (miRNAs) known to be involved in the regulation of immune responses was analyzed in 74 patients with relapsing remitting multiple sclerosis (RRMS) and 32 healthy controls. Four miRNAs (miR-326, miR-155, miR-146a, miR-142-3p) were aberrantly expressed in periphera...
Guardado en:
Autores principales: | Anne Waschbisch, Monika Atiya, Ralf A Linker, Sergej Potapov, Stefan Schwab, Tobias Derfuss |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3cf81de8c2f249a5a29853a0a653fa2f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of glatiramer acetate in the early treatment of multiple sclerosis
por: David W Brandes
Publicado: (2010) -
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
por: Lugaresi A, et al.
Publicado: (2013) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: Fabricio González-Andrade, et al.
Publicado: (2010) -
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
por: Henrik Lund, et al.
Publicado: (2013) -
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.
por: Andreas Keller, et al.
Publicado: (2009)